A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.
Hahn SM, Bernhard EJ, Regine W, Mohiuddin M, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, DeLaney TF, Kiel KD, Morrison B, Deutsch P, Muschel RJ, McKenna WG.
Hahn SM, et al. Among authors: stevenson jp.
Clin Cancer Res. 2002 May;8(5):1065-72.
Clin Cancer Res. 2002.
PMID: 12006520
Clinical Trial.